eClinical Solutions, LLC has been recognized by CIOReview Magazine as the recipient of “Top 20 Pharma & Life Sciences Tech Solution Companies - 2016,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the CIOReview research and editorial team based on insights from an interview with Raj Indupuri, CEO.

eClinical Solutions, LLC
Accelerating the Clinical Development Process

Raj Indupuri, CEO

Cloud and Analytics are two of the most trending technologies doing the rounds in the life sciences landscape. But then, we all know it by now and it doesn’t exactly tickle our curiosity anymore. What is truly curious though is the following statement by Raj Indupuri, CEO, eClinical Solutions. “We, at eClinical, strive to ‘liberate’ the cloud and analytics technologies through our cloud-based data repository and analytics platform—elluminate®, empowering our clients in the process.”

eClinical started as a services organization in 2006, a time when the pharma industry was witnessing sweeping changes, the most prominent being a steep rise in the adoption of clinical systems. “This directly resulted in utilization of multiple service providers, adherence to complex regulatory requirements, and adoption of data standards that gave rise to new challenges,” recalls Indupuri. These challenges, ranging from trial data dispersed in different formats and systems to support efficient reporting and analysis of the data spurred eClinical into developing software, in 2010. Since then, the company is focused on leveraging cloud and analytics and continuously adding innovative capabilities into elluminate.

elluminate utilizes secure cloud-based architecture and offers scalable management of clinical data as well as efficient computing for data analytics. Our end-to-end platform enables clients to seamlessly import data from different sources, formats, and systems into one central repository for self-service analytics. “elluminate requires no infrastructure at the client’s side and successfully delivers mature data integration capabilities,” assures Indupuri. The solution doesn’t require tedious customizations which take a long time to implement along with the spending of massive resources and efforts. Elluminate supports multiple use cases from Risk Based Monitoring (RBM) to Safety Signal Detection and is seamlessly interoperable with other systems. “If a clinical system outputs data in CDISC ODM format, for instance, elluminate can easily import it,” affirms the CEO.

We, at eClinical, strive to ‘liberate’ the cloud and analytics technologies, empowering our clients in the process

In reporting and analysis, if the client uses Study Data Tabulation Model (SDTM) data model, elluminate empowers the clients to integrate the data with a few clicks and publish it. Within a few minutes, clients have access to advanced visualizations which enables decision-makers to look for outliers or identify new patterns. The data that is published is governed and controlled to avoid any integrity or quality issues. “We incorporated several capabilities within the platform to support this governance including meta data management, compliance with standards, and audit trail to ensure the data flows from the source to analytical modules seamlessly,” says Indupuri.

A Boston-based Biotech company, focused on oncology-related clinical trials, was struggling to build databases and designing Case Report Forms (eCRF) for efficient collection. The client’s initial solution provider was unable to provide competent design practices which led to the databases getting too complex to utilize. eClinical, once called in, refurbished the databases in terms of collecting the data elements, and combined complex eCRFs and converted them into simple usable ones. The technical services team extracted data from the redesigned databases and transformed it into useful information while the sponsor team accessed the data and analyzed it easily utilizing elluminate. The client thus gained insightful visibility into tumor response rates and other trends.

eClinical will continue to leverage cloud and analytics to deliver a combination of products and services as, “we firmly believe, to maximize the potential of these technologies, is the Holy Grail for success in pharma and saving lives as never before,” concludes Indupuri.

eClinical Solutions, LLC

eClinical Solutions Strategic Global Business Report 2023-2030: Shift towards Decentralized Clinical Trials to Boost Market Prospects

Thursday, August 22, 2024

Dublin, (GLOBE NEWSWIRE) -- The "eClinical Solutions - Global Strategic Business Report “ report has been added to ResearchAndMarkets.com's offering.

The global market for eClinical Solutions is estimated at US$10.0 Billion in 2023 and is projected to reach US$21.9 Billion by 2030, growing at a CAGR of 11.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the eClinical solutions market is driven by several factors, including increasing number of clinical trials, focus on data quality, government initiatives and broader uptake of EHRs. Clinical research is an integral component of medicine and deal with research efforts to assess efficacy and safety of new drugs, medical devices and diagnostic tools.

Given that clinical trials are time-intensive and expensive in nature, advanced tools such as E-clinical solutions are utilized to streamline all aspects of trials. The market is being driven by the increasing use of healthcare IT solutions by life sciences organizations and government funding to aid innovation in sophisticated solutions for clinical trials.

Increasing uptake of electronic health records (EHR) within the healthcare industry is a prominent driver for the global market. The transition towards EHRs is augmenting the demand for integrated solutions to improve accuracy and efficiency of clinical trials. EHR adoption is also powered by government initiatives along with evolving regulations, prompting healthcare providers to embrace advanced E-clinical solutions for streamlined operations, efficient data management and better patient care.

The global market is also buoyed by increasing investments by private players in new E-clinical solutions offering enhanced usability, capabilities and customization. These tools are enabling healthcare firms to manage their clinical trials, operations and patient data.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global eClinical Solutions Market, covering all major geographic regions and market segments.

• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.

• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global eClinical Solutions Market.

• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Web-Hosted (on-demand) Delivery segment, which is expected to reach US$12.1 Billion by 2030 with a CAGR of a 11.7%. The Cloud-Based Delivery segment is also set to grow at 13.7% CAGR over the analysis period.

• Regional Analysis: Gain insights into the U.S. market, estimated at $3.8 Billion in 2023, and China, forecasted to grow at an impressive 18.0% CAGR to reach $2.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.

• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

• Company Profiles: Coverage of major players such as Advarra, Inc., Anju Software, Inc., BSI Business Systems Integration AG, and more.

• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Attributes:

Report Attribute Details

No. of Pages 446

Forecast Period 2023 - 2030

Estimated Market Value (USD) in 2023 $10 Billion

Forecasted Market Value (USD) by 2030 $21.9 Billion

Compound Annual Growth Rate 11.8%

Regions Covered Global

MARKET OVERVIEW

• A Prelude to eClinical Solutions

• Increase in R&D Costs of a New Approved Drug (1980s-2020s)

• COVID-19 Impact on eClinical Solutions Market

• Competitive Landscape

• eClinical Solutions - Global Key Competitors Percentage Market Share in 2024 (E)

• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

• Global Market Analysis and Prospects

• Global E-Clinical Solutions Market Set to Witness Sturdy Growth

• Growth Drivers/Opportunities

• Exciting Opportunities

• E-Clinical Solution Revolution in Full Swing with Life Sciences & Clinical Research Trends

• Market Restraints/Challenges

• Product/End-use Segment Analysis

• Analysis by Delivery Mode

• End User Analysis

• Regional Market Analysis

• Recent Market Activity

• Select Innovations in eClinical Solutions Market

• Influencer/Product/Technology Insights

MARKET TRENDS & DRIVERS

• Strong Rise in Pharmaceutical Sales to Drive Demand for eClinical Solutions

• Persistent Increase in Pharmaceutical R&D Bodes Well for eClinical Solutions Market

• Rise in Clinical Trials Powers Growth of eClinical Solutions

• Trends in Clinical Trials Space to Influence Market Demand

• Clinical Trials Increasingly Embraced Technology During COVID-19 Pandemic

• Shift towards Decentralized Clinical Trials to Boost Market Prospects

• Demand for eClinical Solutions from CROs Set to Increase Rapidly

• AI & Blockchain: Double Drivers for E-Clinical Solutions Market

• The Use of Artificial Intelligence to Increase Efficacy of Clinical Research

• Increased Popularity of Electronic Clinical Outcomes Assessments

• eCOA & ePRO: A Powerful Duo Serving Clinical Trials with Electronic Data Collection

FOCUS ON SELECT PLAYERS(Total 85 Featured)

• Advarra, Inc.

• Anju Software, Inc.

• BSI Business Systems Integration AG

• Castor

• eClinical Solutions LLC

• Fountayn

• MaxisIT Inc.

• Medidata Solutions, Inc.

• MedNet Solutions, Inc.

• Medrio, Inc.

• Merative L.P.

• Oracle Corporation

• Parexel International Corporation

• Saama Technologies, LLC

• Veeva Systems Inc.

eClinical Solutions Announces Growth Investment by GI Partners to Further Its Mission of Helping Bring Treatments to Patients Faster

Thursday, September 26, 2024

BOSTON- eClinical Solutions LLC, announced that GI Partners, a private investment firm, has made a majority investment in the company. This affirms eClinical Solutions’ position as a trusted partner for large, mid-size, and emerging life science organizations looking to accelerate research and drive tomorrow’s therapeutic breakthroughs amid growing trial complexity. Additionally, GI Partners’ investment in eClinical reflects its longstanding commitment to backing industry leaders providing critical services to growing sectors. Financial terms of the private transaction remain confidential.

Headquartered in the Boston metropolitan area, one of the nation’s leading pharma and biotech innovation hubs, eClinical Solutions has been creating technology to help solve the market’s growing clinical data challenges since its founding in 2012. The company’s elluminate Clinical Data Cloud® SaaS platform is designed to optimize data flows, accelerate cycle times and increase productivity to future proof clinical trials for clients. Recognized as a leader in the data infrastructure and analytics category, eClinical works with 16 of the Top 50 biopharmaceutical companies, helping them unlock the value of their data with modern infrastructure.

“When we founded eClinical over a decade ago, clinical data volume and complexity were beginning to escalate rapidly. To improve trial efficiency and help pharmaceutical companies keep up with the mounting pressure to shorten timelines, we had a vision to create frictionless data flows enabled by cloud and digital platforms,” said Raj Indupuri, co-founder and CEO of eClinical Solutions, who will continue to lead the company along with the current management team. “A lot has changed over the years, but our mission hasn’t. We are helping our clients get treatments to patients faster by providing them with a data infrastructure and analytics foundation that powers critical efficiencies across the R&D lifecycle. GI’s support will help fuel the next phase of our company’s journey, as we look to deepen our product roadmap, extend embedded AI capabilities, and help drive future-ready trials.”

“We’re incredibly proud of the organization we’ve built and are excited to partner with GI Partners as we embark on this next chapter of growth,” added Bob Arnesen, co-founder and president of eClinical. “GI’s track record in scaling biopharmaceutical technology businesses and their deep understanding of our market will ensure we can execute our strategy of reliably delivering value to our clients and partners."

“Raj, Bob and their team have built an exceptional business and an industry-leading platform empowering faster, informed decision-making in clinical trials to drive biopharma innovation for the customers they serve,” said Dave Kreter, managing director at GI Partners.

Summit Partners, an investor in eClinical since 2020, will continue to hold a minority position in the company. eClinical’s founders will also retain a significant equity stake alongside GI Partners.

“We’ve been honored to be a part of the eClinical growth story over the last several years, as the company has scaled both in size and impact,” said Mark deLaar, a managing director at Summit Partners. “It’s a pleasure to welcome GI Partners, and we look forward to working together to support the company’s continued development of innovative solutions that empower eClinical customers worldwide.”

Guggenheim Securities, LLC served as exclusive financial advisor to eClinical Solutions. Morse, Barnes-Brown & Pendleton, and Choate Hall & Stewart LLP served as legal counsel to eClinical Solutions. Leerink Partners and J.P. Morgan served as financial advisors and Ropes & Gray LLP served as legal advisors to GI Partners.

The transaction is expected to close in the third quarter of 2024, subject to customary closing conditions and regulatory approvals.

Top 20 Pharma & Life Sciences Tech Solution Companies - 2016

Company
eClinical Solutions, LLC

Management
Raj Indupuri, CEO

Description
Provides customized data management services and Clinical Data Repository platform with advanced visualization and analytical capabilities

eClinical Solutions, LLC Accelerating the Clinical Development Process